[Table], Table 1. Key drugs registered for the treatment of parasitic worms in humans.
Lindy Holden‐Dye(University of Southampton), Robert J. Walker(University of Minnesota System)
Unknown
January 1, 2005
Cited by 0
Related Papers
Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans
|WormBook|2014|172
Evolution and overview of classical transmitter molecules and their receptors
|Parasitology|1996|134
Fluensulfone is a nematicide with a mode of action distinct from anticholinesterases and macrocyclic lactones
|Pesticide Biochemistry and Physiology|2014|130
Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission
|Neurogenetics|1998|130
A review of FMRFamide- and RFamide-like peptides in metazoa
|Invertebrate Neuroscience|2009|129